Oost NL

Venture capital · Apeldoorn, Netherlands

Founded in 2003, Oost NL is a venture capital investment firm based in Apeldoorn, Netherlands. 43 portfolio companies are on record.

AUM
—
Portfolio companies
43
Recorded deals
1
Last investment
—

Oost NL key facts

  • Oost NL is a venture capital firm based in Apeldoorn, Netherlands with 43 tracked portfolio companies.
  • Notable positions include Pleco Therapeutics, Bilihome, New Origin.
  • The team roster lists 73 people.

About Oost NL

Founded in 2003, Oost NL is a venture capital investment firm based in Apeldoorn, Netherlands. The firm prefers to invest in food, energy, health, logistics, and technology sectors in the Netherlands.

Oost NL portfolio at a glance

43 portfolio companies are on record for Oost NL, including Pleco Therapeutics, Bilihome and New Origin.

3 of the 43 carry a recorded valuation.

Oost NL team

73 people are on record at Oost NL: 9 advisors, 4 partners, 3 analysts and 57 others. Senior names include Fons de Zeeuw (Director), Freek Welling (Director of Capital) and Wendy Jong (Director). 73 of them have a verified direct contact on file.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 43 recorded positions
  • ·Watchlist + alerts for Oost NL's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

43 companies · priced for members
CompanyValuationRole
Pleco Therapeutics▮▮
Bilihome▮▮
New Origin▮▮
+ 40 more companies · all 43, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Team
73 people on record — 73 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about Oost NL

What companies does Oost NL invest in?
Oost NL has 43 recorded portfolio companies, including Pleco Therapeutics, Bilihome, New Origin.